Reported Reactions

Devices › Device types

FDA product code NJK · class 3 · Unknown

Valve, pulmonary: medical device reports filed with FDA

2,017 reports carry this product code, 2018–2026; 2 brands with a page.

2,017
reports with this product code
0% of all MAUDE reports
156
reports, 12 months to August 2026
169 in the 12 months before
6.1%
classified as malfunction
62.3% across all reports
8.9%
classified as death, as reported
0.9% across all reports

Product code NJK is FDA's classification for "Valve, pulmonary" (unknown panel), a class 3 device. 2,017 medical device reports carry this product code, 0% of the MAUDE database, from November 2018 to August 2026.

156 reports arrived in the 12 months to August 2026, close to the 169 of the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (85%), death (8.9%) and malfunction (6.1%). 2 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Brands with this product code

BrandReportsLatest 12 monthsClassified as deathClassified as malfunction
Zephyr Endobronchial Valve (EBV)1,209769.9%2.1%
Zephyr Endobronchial Valve4521410.4%12.4%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Manufacturers named

Manufacturer (as written on reports)ReportsShare
Pulmonx1,20459.7%
Gyrus Acmi24812.3%

Reports by month, five years

02651Sep 2021: 40Oct 2021: 36Nov 2021: 43Dec 2021: 392022Jan 2022: 28Feb 2022: 22Mar 2022: 29Apr 2022: 27May 2022: 44Jun 2022: 51Jul 2022: 14Aug 2022: 14Sep 2022: 35Oct 2022: 22Nov 2022: 36Dec 2022: 202023Jan 2023: 21Feb 2023: 21Mar 2023: 44Apr 2023: 7May 2023: 40Jun 2023: 20Jul 2023: 27Aug 2023: 9Sep 2023: 22Oct 2023: 17Nov 2023: 25Dec 2023: 132024Jan 2024: 7Feb 2024: 17Mar 2024: 5Apr 2024: 16May 2024: 8Jun 2024: 27Jul 2024: 21Aug 2024: 5Sep 2024: 9Oct 2024: 8Nov 2024: 23Dec 2024: 302025Jan 2025: 14Feb 2025: 9Mar 2025: 16Apr 2025: 20May 2025: 7Jun 2025: 9Jul 2025: 17Aug 2025: 7Sep 2025: 16Oct 2025: 5Nov 2025: 14Dec 2025: 142026Jan 2026: 0Feb 2026: 25Mar 2026: 13Apr 2026: 14May 2026: 17Jun 2026: 20Jul 2026: 17Aug 2026: 1

FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

Event type and report source

Event type

Death8.9%179
Injury85%1,714
Malfunction6.1%124
Other0%0
Not given0%0

Who filed

Manufacturer report99.4%2,004
Voluntary report0.2%5
User facility report0%0
Distributor report0%0
Not given0.4%8

Grey bar: all 26,136,888 MAUDE reports.

Device problems coded

Device problem (FDA code)ReportsShare
Material split, cut or torn1025.1%
Insufficient device problem information572.8%
Migrationthe device moved from where it was placed90.4%
Detachment of device or device componentpart of the device came off80.4%
Difficult to removethe device was hard to remove40.2%
Non reproducible results40.2%
Lack of effect30.1%
Unexpected therapeutic results30.1%
Defective component20.1%
Material integrity problema problem with the device material20.1%
Off-label use20.1%
Activation failure10%
Activation, positioning or separation problem10%
Defective devicethe device was defective10%
Device contamination with body fluid10%
Device contamination with chemical or other material10%
Device damaged prior to usethe device was damaged before use10%
Difficult to open or close10%
Firing problem10%
Gas/air leak10%

Questions about valve, pulmonary reports

What is product code NJK?

FDA's classification code for "Valve, pulmonary", class 3, reviewed by the unknown panel. Every device report carries the product code of the device involved.

How many reports carry this code?

2,017 reports through August 2026, 156 of them in the latest 12 months.

Which brands appear most often?

Zephyr Endobronchial Valve (EBV) (1,209) and Zephyr Endobronchial Valve (452). Widely used products collect more reports because more people use them.

Can the brands table be used to rank the devices?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.